<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00671229</url>
  </required_header>
  <id_info>
    <org_study_id>12496-CP-006A</org_study_id>
    <secondary_id>Pro00005046</secondary_id>
    <nct_id>NCT00671229</nct_id>
  </id_info>
  <brief_title>Nitric Oxide, LPS and the Pathogenesis of Asthma Phase 1</brief_title>
  <official_title>Nitric Oxide, LPS and the Pathogenesis of Asthma Phase 1</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Environmental Health Sciences (NIEHS)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sandler Program for Asthma Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Institute of Environmental Health Sciences (NIEHS)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine the role of nitric oxide (NO) in asthma. We&#xD;
      determine the effect of promoter polymorphisms in the gene for the NO producing enzyme,&#xD;
      nitric oxide synthase (NOS2), on exhaled NO in healthy African Americans and Caucasians. We&#xD;
      compare exhaled NO levels between African Americans and Caucasians. Information on race or&#xD;
      ethnicity, serum samples, blood pressure, exhaled breath condensate and health questionnaires&#xD;
      will be collected.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of the study is to determine the role of nitric oxide (NO) in asthma. We&#xD;
      determine the effect of promoter polymorphisms in the gene for the NO producing enzyme,&#xD;
      nitric oxide synthase (NOS2), on exhaled NO in healthy African Americans and Caucasians. We&#xD;
      compare exhaled NO levels between African Americans and Caucasians. Information on race or&#xD;
      ethnicity, serum samples, blood pressure, exhaled breath condensate and health questionnaires&#xD;
      will be collected.&#xD;
&#xD;
      Three single nucleotide polymorphisms (SNPs) have been identified in Africans that are&#xD;
      associated with increases in systemic NO production. These studies determine whether the NOS2&#xD;
      promoter SNPs are associated with differences in basal exhaled NO levels. The study of&#xD;
      exhaled NO levels in individuals with asthma is confounded by the presence of cell types&#xD;
      besides bronchial epithelium that produce NO, by differences in the severity of asthma and by&#xD;
      the use of medications such as corticosteroids which alter exhaled NO levels.&#xD;
&#xD;
      Therefore, in this study exhaled NO levels in asymptomatic healthy African Americans and&#xD;
      Caucasians are measured. The initial analysis of exhaled NO levels indicate that a subset of&#xD;
      African American samples contained lower levels of NO than previous measurements of exhaled&#xD;
      NO levels in Caucasians. Because differences in exhaled NO levels may influence&#xD;
      bronchodilation and other airway responses, as part of this study, the exhaled NO levels of&#xD;
      the African American subjects are compared to the results of sample collections from&#xD;
      Caucasian samples.&#xD;
&#xD;
      In addition to measures of exhaled NO levels, information on race or ethnicity and DNA&#xD;
      samples are collected to characterize samples collected from African American and Caucasian&#xD;
      subjects. Serum samples, measures of blood pressure and exhaled breath condensate samples are&#xD;
      collected from African Americans and Caucasians to control for confounding variables.&#xD;
      Repeated measures of exhaled NO levels are collected to control for fluctuations in exhaled&#xD;
      NO levels related to upper respiratory infections.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2003</start_date>
  <completion_date type="Actual">June 2008</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">420</enrollment>
  <condition>Healthy</condition>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>African American</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Caucasian</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum samples, DNA, Exhaled Breah Condensate&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Community sample&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Willing/able to give informed consent&#xD;
&#xD;
          -  self declared non-atopic, non-asthmatic&#xD;
&#xD;
          -  never cigarette smoker,&#xD;
&#xD;
          -  no significant occupational exposure to respiratory irritants or toxins,&#xD;
&#xD;
          -  no chronic illness&#xD;
&#xD;
          -  no chronic use of medications (excluding contraceptive medication),&#xD;
&#xD;
          -  no historical unstable cardiac or severe lung disease,&#xD;
&#xD;
          -  within study age parameters of 18 - 40&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  occupational exposure to hay or grain&#xD;
&#xD;
          -  smoked 20 or more packs of cigarettes in a lifetime.&#xD;
&#xD;
          -  prior allergen immunotherapy&#xD;
&#xD;
          -  Allergy and or asthma&#xD;
&#xD;
          -  Students or employees under direct supervision by protocol investigators are&#xD;
             ineligible&#xD;
&#xD;
          -  Nursing mothers&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  Other investigational medication within the last 30 days&#xD;
&#xD;
          -  Other medical or psychological conditions which, in the opinion of the investigator,&#xD;
             might create undue risk to the subject or interfere with the subject's ability to&#xD;
             comply with the protocol requirements&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc C Levesque, M.D., PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Levesque MC, Hauswirth DW, Mervin-Blake S, Fernandez CA, Patch KB, Alexander KM, Allgood S, McNair PD, Allen AS, Sundy JS. Determinants of exhaled nitric oxide levels in healthy, nonsmoking African American adults. J Allergy Clin Immunol. 2008 Feb;121(2):396-402.e3. Epub 2007 Nov 26.</citation>
    <PMID>18036642</PMID>
  </results_reference>
  <verification_date>April 2015</verification_date>
  <study_first_submitted>May 2, 2008</study_first_submitted>
  <study_first_submitted_qc>May 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2008</study_first_posted>
  <last_update_submitted>April 13, 2015</last_update_submitted>
  <last_update_submitted_qc>April 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 14, 2015</last_update_posted>
  <responsible_party>
    <name_title>Marc C. Levesque</name_title>
    <organization>NIEHS</organization>
  </responsible_party>
  <keyword>Healthy</keyword>
  <keyword>Asthma</keyword>
  <keyword>Nitric Oxide</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

